Security record · archived quarter
PRAX
Praxis Precision Medicines, Inc. · Healthcare · Biotechnology
12Tracked holders
—Δ holders
4.09MShares held
$168.97MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 111 | +10 | 16.57M | $5.55B | +16 | −5 |
| Q1 2026 | 103 | +2 | 17.55M | $5.65B | +11 | −10 |
| Q4 2025 | 101 | +1 | 18.04M | $5.32B | +2 | — |
| Q3 2025 | 17 | +1 | 10.82M | $573.60M | +1 | −1 |
| Q2 2025 | 14 | 0 | 8.51M | $357.72M | +1 | −1 |
| Q1 2025 | 11 | -2 | 4.62M | $175.13M | — | −2 |
| Q4 2024 | 13 | 0 | 4.07M | $313.25M | — | — |
| Q3 2024 | 12 | 0 | 3.95M | $227.16M | +1 | −1 |
| Q2 2024 | 12 | — | 4.09M | $168.97M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 1.13M | — | $46.91M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Point72 Asset Management ✦ | 1.05M | — | $43.50M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 938.58K | — | $38.82M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 938.58K | — | $38.82M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 395.06K | — | $16.34M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 395.06K | — | $16.34M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Marshall Wace ✦ | 248.38K | — | $10.27M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 248.38K | — | $10.27M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Millennium Management ✦ | 90.91K | — | $3.76M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 75.43K | — | $3.12M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 51.51K | — | $2.13M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 51.51K | — | $2.13M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 51.51K | — | $2.13M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Norges Bank ✦ (passive) | 32.01K | — | $1.32M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 23.97K | — | $991,234 | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 22.65K | — | $936,639 | 0.0% | n/c | 1 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 21.08K | — | $871,745 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 287 holders, 28.34M shares, $8.85B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API